Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol in Endovascular Procedures for Cerebrovascular Disorders
NCT04950621Completed
- Sponsor
- Air Force Medical University
- Start
- Jul 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of remimazolam in cerebrovascular disease (2 arms), sponsored by Air Force Medical University. Primary endpoint: Time to open eye at 15 minutes. Started Jul 2021; status: completed.
02
Drugs
remimazolam
03
Conditions
cerebrovascular disease
Beyond the preview
Go deeper on NCT04950621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04950621.